住院期间抗栓治疗与华法林经皮冠状动脉介入治疗老年患者的结局：来自 WAR-STENT 登记研究的观察。
In-hospital antithrombotic therapy and outcomes of elderly patients on warfarin undergoing percutaneous coronary intervention: Insights from the WAR-STENT registry.
机构信息
Division of Cardiology, Maggiore Hospital, Bologna, Italy.
Cardiovascular Institute, University Hospital, Ferrara, Italy; Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
出版信息
Indian Heart J. 2022 May-Jun;74(3):256-257. doi: 10.1016/j.ihj.2022.04.011. Epub 2022 May 4.
Abstract
In the patients on warfarin undergoing percutaneous coronary intervention included in the prospective, multicentre, observational WAR-STENT registry, age ≥75 years was associated with a significant increase in in-hospital major bleeding, length of hospitalization, and use of bare-metal stents, with no differences in the peri-procedural management and antithrombotic therapy.
摘要
在前瞻性、多中心、观察性 WAR-STENT 注册研究中纳入的正在接受经皮冠状动脉介入治疗的华法林患者中，年龄≥75 岁与住院期间大出血、住院时间延长和使用裸金属支架显著增加相关，而在围手术期管理和抗血栓治疗方面没有差异。
相似文献
1
In-hospital antithrombotic therapy and outcomes of elderly patients on warfarin undergoing percutaneous coronary intervention: Insights from the WAR-STENT registry.住院期间抗栓治疗与华法林经皮冠状动脉介入治疗老年患者的结局：来自 WAR-STENT 登记研究的观察。
Indian Heart J. 2022 May-Jun;74(3):256-257. doi: 10.1016/j.ihj.2022.04.011. Epub 2022 May 4.
2
[Periprocedural management of anticoagulation therapy and in-hospital outcomes in patients with warfarin indication undergoing percutaneous coronary intervention. Data from the WAR-STENT registry].[华法林适用的经皮冠状动脉介入治疗患者围手术期抗凝治疗管理及院内结局。来自WAR-STENT注册研究的数据]
G Ital Cardiol (Rome). 2021 Jan;22(1):62-67. doi: 10.1714/3502.34884.
3
Twelve-month outcome of patients with an established indication for oral anticoagulation undergoing coronary artery stenting and stratified by the baseline risk of bleeding: Insights from the Warfarin and Coronary Stenting (War-Stent) Registry.接受冠状动脉支架置入术且有口服抗凝既定适应症的患者的12个月预后，并按基线出血风险分层：来自华法林与冠状动脉支架置入术（War-Stent）注册研究的见解
Cardiovasc Revasc Med. 2017 Sep;18(6):425-430. doi: 10.1016/j.carrev.2017.03.015. Epub 2017 Mar 19.
4
5
Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.经皮冠状动脉介入治疗后心房颤动患者抗栓治疗的时间趋势和治疗差距：来自 CHUM AF-STENT 登记研究的见解。
Clin Cardiol. 2020 Mar;43(3):216-221. doi: 10.1002/clc.23316. Epub 2019 Dec 18.
6
Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.经皮冠状动脉介入治疗中房颤患者的临床结局与操作程序及冠状动脉病变特征的相关性：来自 PIONEER AF-PCI 试验的研究结果。
JACC Cardiovasc Interv. 2018 Apr 9;11(7):626-634. doi: 10.1016/j.jcin.2017.11.009. Epub 2018 Mar 14.
7
8
Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.药物洗脱支架植入术后房颤患者三联抗栓治疗与双联抗血小板治疗的比较
Coron Artery Dis. 2015 Aug;26(5):372-80. doi: 10.1097/MCA.0000000000000242.
9
In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.美国房颤抗凝时代华法林和直接口服抗凝剂致心肌梗死患者院内出血结局：来自全国心血管数据注册急性冠脉治疗和干预结局网络注册的报告。
J Am Heart Assoc. 2019 Apr 16;8(8):e011606. doi: 10.1161/JAHA.118.011606.
10
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。
Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
引用本文的文献
1
Enhanced Reendothelialization and Thrombosis Prevention with a New Drug-Eluting Stent.新型药物洗脱支架增强再内皮化及预防血栓形成
Cardiovasc Drugs Ther. 2024 Jun 4. doi: 10.1007/s10557-024-07584-y.
本文引用的文献
1
Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries.美国医疗保险受益人群中临床医生开具直接口服抗凝药物的趋势。
JAMA Netw Open. 2021 Dec 1;4(12):e2137288. doi: 10.1001/jamanetworkopen.2021.37288.
2
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.急性冠状动脉综合征和/或经皮冠状动脉介入治疗/支架置入术的心房颤动患者的抗栓治疗管理。
Thromb Haemost. 2010 Jan;103(1):13-28. doi: 10.1160/TH09-08-0580. Epub 2009 Sep 30.
3
A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.一项关于接受冠状动脉支架置入术的口服抗凝治疗患者管理的前瞻性多中心观察性研究：正在进行的华法林与冠状动脉支架置入术（WAR-STENT）注册研究的原理与设计。
J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):200-3. doi: 10.2459/JCM.0b013e3283212f07.
Zotero 插件